Stockreport

Mural Oncology Highlights Clinical Trials During It's Maiden Investor Day [Forbes]

Mural Oncology plc - Ordinary Shares  (MURA) 
PDF Mural Oncology (NASDAQ: MURA, $3.05, Market Capitalization $52.0 million), a clinical-stage oncology company focused on discovering and developing immunotherapies, held [Read more]